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The ultimate goals for stem cell researchers are uncovering
the fundamental mechanisms of cellular biology as well as
developing treatments for disease and/or injury. The central
nervous system (CNS) presents an unparalleled challenge
for these studies due to the diversity of cell types and
their interrelated functions in health and disease. Further-
more, the endpoints for determining phenotypic maturation
are complicated by the fact that cells, especially neurons,
express a plethora of receptors and ion channels that control
excitability and plasticity which vary greatly between CNS
regions. For this reason, extensive effort has been placed on
developing methods to differentiate appropriate populations
of cells that reside within the CNS (e.g., neuronal subtypes,
astrocytes, and oligodendrocytes). These studies typically
employ phenotypic validation by the use of expression anal-
ysis for various protein markers of regionalized populations,
with a burgeoning effort to verify functional outcomes.Much
of this work has been informed by basic developmental
studies that have identified cell-intrinsic and cell-extrinsic
signaling mechanisms, as well as transcriptional programs
involved with cell fate specification.
While early work focused on the use of mesenchymal
stem cells, embryonic carcinoma cells, and fetal stem cells,
more recent efforts have focused on the areas of human
embryonic stem cells (hESCs) and induced pluripotent stem
cells (iPSCs). These sources typically require slightly differ-
ent methods to direct differentiation to various CNS fates,
although many mechanisms appear to converge on common
signaling pathways. Many recent studies have even success-
fully uncovered cell-type specific phenotypes that are appro-
priate for various human diseases. However, despite these
advances, limitations still hamper the application of human
stem cells for CNS development/disease studies. First, most
differentiation protocols lead to a heterogeneity of cells in
terms of both their “regional”markers and theirmaturational
states. Furthermore, the number and diversity of available
fate-specific biomarkers remain insufficient to unambigu-
ously identify regional and transmitter phenotypes.
In this special issue, we highlight both the advancements
and challenges of directed differentiation of various neuronal
and glial cells from pluripotent stem cells. We hope this
collection of works will provide readers with a resource
to understand directed differentiation, functional matura-
tion, and transplantation-induced changes to host environ-
ments.
The article by P. Prajumwongs et al. reviews the current
state of knowledge regarding neural induction of human
pluripotent stem cells, detailing the signaling pathways and
timing of critical events such as neuroepithelial differentia-
tion. Emphasis is placed on the comparison between in vitro
and in vivo development and the utility of hESCs to model
human-specific signaling processes. The article concludes
with a series of brief descriptions about various develop-
mental and neurodegenerative diseases and how iPSCs have
been used to model their underlying molecular and cellular
pathologies.
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The review article from A. Zirra et al. gives a detailed
overview of the development of the neural tube and how
these in vivo principles provided the basis for in vitro
neural induction strategies of human pluripotent stem cells
(hPSCs). The article highlights the basic stages of neural
development including neural induction, neurulation, and
neural patterning. Here they focus on signaling pathways,
morphogenes, and patterning factors described to be crucial
for the development of distinct brain regions. The authors
then discuss how knowledge from in vivo brain development
has been translated by many groups to direct the differentia-
tion of hPSCs to clinically relevant region-specific neurons
in vitro. Finally, they give an outlook of how human brain
development data can be utilized for improving directed
differentiation protocols and validating the thereof derived
region-specific subpopulations of human neurons.
The article by F. Cavaliere et al. reviews the use of organ-
otypic hippocampal slice cultures as a model for understand-
ing neurogenesis under normal and pathological conditions.
They first present a historical summary of the development of
slice cultures fromneonatal, andmore recently adult animals,
for the study of neurogenesis from both SVZ and DGZ.
The article also describes results from pathological studies
of slice cultures in the context of ischemia, Parkinson’s, and
Alzhemier’s disease, as well as regeneration of neurons in the
spinal cord. The authors suggest that the maintenance of the
3D architecture and cellular composition of these cultures
make them unique among in vitro models for these types of
studies.
The primary research article from T. H. Shin et al. tested
the effects of mesenchymal stem cells on polyamine levels
in both in vitro and in vivo models of ischemic stroke.
Polyamines are low molecular weight compounds secreted
in high concentrations from the brain and are important
indicators of metabolic function, especially in response to
injury or disease. The authors found that middle cerebral
artery occlusion (MCAo) in vivo and oxygen-glucose depri-
vation (OGD) of a neural cell line in vitro significantly altered
a plurality of polyamine levels. Importantly, the authors
found that disruptions of polyamine levels by MCAo- and
OGD-induced ischemic conditions could be restored to near-
normal levels after introduction of human bone marrow-
derived mesenchymal stem cells.
Finally, the review article from J. P. Weick highlights
the efforts by many groups to understand the functional
phenotypes of pluripotent stem cell-derived neurons as well
as directly converted/induced neurons (iNs). This article
focuses on the assessment of developmental maturation of
forebrain neurons via analysis of forebrain glutamatergic and
GABAergic currents, comparing these in vitro findings to
in vivo data from rodent models. The author then discusses
recent results modeling various neurological disorders using
iPSC-derived neurons and iNs. He concludes by critically
reflecting on the use of these two cell types for developmental
and disease studies and provides suggestions on how to
optimally determine and report neuronal function.
Together, the articles in this special issue highlight recent
advances in our understanding of the directed differentiation
and functional properties of stem cells and describe several
new approaches to model and develop novel therapies for
neurological disease and injury.
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